AQS-14680-05053
4 vaccinations
11 coded responses
22 check-ins
10 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 949 / CA
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Registered in v-safe
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue — Feeling: Good · Site: Pain, SwellingFree text: slightly tired after the shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
- 2021-01-21
- 2021-01-24
-
2021-01-30
Survey response — day 14, dose 1MedDRA: Headache, Injection site pain, Pyrexia — Feeling: GoodFree text: had headache and very low grade fever very briefly now OKwas exercising arms and slight soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
-
2021-02-07
Dose 2 — Pfizer-BioNTech
- 2021-02-13
- 2021-02-14
- 2021-02-21
-
2021-02-28
Survey response — day 21, dose 2MedDRA: Headache — Feeling: GoodFree text: ocvasional headaches not had before otherwise OKMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
-
2021-03-15
Survey response — day 35, dose 2MedDRA: Headache, Oral herpes — Feeling: FairFree text: continued occasional headachechronic cold soresMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — day 42, dose 2MedDRA: Fatigue, Headache — Feeling: FairFree text: just more tired and occasional headache but not as muchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-09
Survey response — 3 months, dose 2MedDRA: Gastrooesophageal reflux disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: worsened acid reflexMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-09
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-10
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Pre-existing disease — Feeling: FairFree text: some breathing problems but have lung problemsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-04
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — day 21, dose 3MedDRA: Lung disorder, Respiratory disorder — Feeling: FairFree text: some breathing probs from lung issuedMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
- 2021-10-09
-
2021-10-17
Survey response — day 42, dose 3MedDRA: Gastrooesophageal reflux disease — Feeling: FairFree text: GERD is worse but not sure if relatedMedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Dose 4 — Pfizer-BioNTech
-
2022-04-24
Survey response — day 21, dose 4MedDRA: Gastrointestinal disorder, Surgery, Unevaluable event — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: had surgery 3 months ago and last month or so have GI problems where surgety was · Healthcare visit (other): endoscopyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Report sent to call center — day 21, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-25
-
2022-05-09
Call successfulNot applicable - Accidental Reporting
- 2022-10-04
-
2023-04-03
Survey response — 12 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-07 | Pfizer-BioNTech | |
| 3 | 2021-09-04 | Pfizer-BioNTech | No |
| 4 | 2022-04-02 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): slightly tired after the shot
Release 3 — day 14, dose 1
Symptoms: had headache and very low grade fever very briefly now OKwas exercising arms and slight soreness at injection site
Release 4 — day 21, dose 2
Symptoms: ocvasional headaches not had before otherwise OK
Release 5 — day 35, dose 2
Symptoms: continued occasional headachechronic cold sores
Release 6 — day 42, dose 2
Symptoms: just more tired and occasional headache but not as much
Release 8 — 3 months, dose 2
Symptoms: worsened acid reflex
Release 9 — 6 months, dose 2
Symptoms: some breathing problems but have lung problems
Release 9 — day 21, dose 3
Symptoms: some breathing probs from lung issued
Release 10 — day 42, dose 3
Symptoms: GERD is worse but not sure if related
Release 11 — day 21, dose 4
Symptoms: had surgery 3 months ago and last month or so have GI problems where surgety was
Healthcare visit (other): endoscopy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Lung disorder | · | · | ✓ |
| SD | Oral herpes | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Surgery | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release